diff --git a/measures/2024/measures-data.json b/measures/2024/measures-data.json
index 980b6c32..fc1232ce 100644
--- a/measures/2024/measures-data.json
+++ b/measures/2024/measures-data.json
@@ -20283,28 +20283,9 @@
     "measureSets": [],
     "isRegistryMeasure": true,
     "isIcdImpacted": false,
-    "metricType": "registryMultiPerformanceRate",
+    "metricType": "registrySinglePerformanceRate",
     "submissionMethods": [
       "registry"
-    ],
-    "overallAlgorithm": "overallStratumOnly",
-    "strata": [
-      {
-        "name": "noRestrictions",
-        "description": "Normal arterial supply based on testing- No restrictions on type of compression"
-      },
-      {
-        "name": "specialConsideration",
-        "description": "Compression bandaging with special considerations (e.g., short stretch bandaging, warnings to the patient to remove bandages if they feel too tight, etc.)"
-      },
-      {
-        "name": "notRecommended",
-        "description": "Compression bandaging not recommended"
-      },
-      {
-        "name": "overall",
-        "description": "The average of the three risk stratified buckets which will be the performance rate in the JSON XML submitted."
-      }
     ]
   }
 ]
\ No newline at end of file
diff --git a/measures/2025/measures-data.json b/measures/2025/measures-data.json
index 03608f4e..e7b2a6f0 100644
--- a/measures/2025/measures-data.json
+++ b/measures/2025/measures-data.json
@@ -13649,7 +13649,7 @@
     "title": "Improvement in Pain Assessment Following Spine Fusion Procedures",
     "description": "Percentage of patients with patient-reported meaningful improvement in pain following lumbar or cervical spine procedures",
     "nqfId": null,
-    "measureType": "outcome",
+    "measureType": "patientReportedOutcome",
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
@@ -13698,7 +13698,7 @@
     "measureId": "ABFM14",
     "title": "Measuring the Value-Functions of Primary Care: Physician Level Continuity of Care Measure",
     "description": "The measure calculates the percentage of a physician’s patients who have a continuity index of at least 0.7 (excluding patients with < 2 primary care visits during the measurement period). This is a physician-level measure for use in evaluating physician behavior; it leverages a previously validated continuity index that quantifies the extent to which patients experience continuity of provider in their primary care visits.\r\n\r\nThis measure evaluates the extent to which primary care physicians (PCPs) are supporting the continuity of care of their patients. High care continuity is shown to improve patient outcomes and physician well-being, is associated with decreased health care costs (total, ED, inpatient, primary care, and costs for specific conditions or treatments) and health care utilization (ED visits and hospitalizations). As a byproduct of building a trusting relationship over time, issues of equity and social risk can be addressed. Physicians who perform better are likely to have specific structures and processes in place that are conducive to allowing patients to achieve higher care continuity. \r\n\r\nCompared to lower scores (e.g., 0.6 or lower), continuity index scores of 0.7 or higher have been associated with significantly lower Medicare expenditures and significantly lower odds of hospitalization.1 \r\n\r\nReferences: \r\n1. Higher Primary Care Physician Continuity is Associated with Lower Costs and Hospitalizations. Bazemore et al. Annals of Family Medicine. 2018. 16, 492-497.",
-    "nqfId": null,
+    "nqfId": "3617",
     "measureType": "efficiency",
     "isHighPriority": true,
     "isInverse": false,
@@ -14655,7 +14655,7 @@
   {
     "measureId": "AQI77",
     "title": "Opioid Use Disorder Risk Screening and Referral",
-    "description": "Percentage of patients, 18 years and older, who undergo a surgical procedure requiring anesthesia services who are screened for risk of opioid use disorder using a standardized screening tool and, if the patient test positive for risk of opioid use disorder, are referred to a treatment program according to facility policies and procedures.",
+    "description": "Percentage of patients, 18 years and older, who undergo a surgical procedure requiring anesthesia services who are screened for risk of opioid use disorder using a standardized screening tool and, if the patient tests positive for risk of opioid use disorder, are referred to a treatment program according to facility policies and procedures.",
     "nqfId": null,
     "measureType": "process",
     "isHighPriority": true,
@@ -15157,7 +15157,7 @@
   {
     "measureId": "AQI78",
     "title": "Preoperative Older Adult Cognitive Assessment and Implementation of Older Adult Best Practices in Elective Surgeries",
-    "description": "Percentage of patients, aged 70 and older, who undergo an elective surgical procedure under general anesthesia who receive a cognitive screening using a validated tool(s) within 90 days prior to their procedure and, for those who screen positive for cognitive impairment or cognitively at-risk, have two or more perioperative best practices for the older adult applied to their care. \r\n\r\nInstructions:\r\nThis measure consists of a weighted average of two performance rates: \r\nNumerator Criteria 1:\r\nPatients received a cognitive screening using a validated tool within 90 days prior to their elective surgical procedure.    \r\nNumerator Criteria 2:\r\nPatients with a positive cognitive screening or cognitively at-risk using a validated tool within 90 days prior to their elective surgical procedure received two or more perioperative best practices for the older adult applied to their care.\r\n\r\nIt is anticipated that qualified anesthesia professionals and eligible clinicians who provide denominator-eligible services will submit this measure.",
+    "description": "Percentage of patients, aged 70 and older, who undergo an elective surgical procedure under general anesthesia who receive a cognitive screening using a validated tool(s) within 90 days prior to their procedure and, for those who screen positive for cognitive impairment or cognitively at-risk, have two or more perioperative best practices for the older adult applied to their care. \n\nInstructions:\nThis measure consists of a weighted average of two performance rates: \nNumerator Criteria 1:\nPatients received a cognitive screening using a validated tool within 90 days prior to their elective surgical procedure.    \nNumerator Criteria 2:\nPatients who screened positive for cognitive impairment or cognitively at risk (positive cognitive screening or positive cognitively at-risk) using a validated tool within 90 days prior to their elective surgical procedure received two or more of the perioperative best practices for the older adult applied to their care.\n\nIt is anticipated that qualified anesthesia professionals and eligible clinicians who provide denominator-eligible services will submit this measure.",
     "nqfId": null,
     "measureType": "process",
     "isHighPriority": true,
@@ -15203,7 +15203,7 @@
   {
     "measureId": "AQI79",
     "title": "Neuromuscular Blockade and Quantitative Train-of-Four",
-    "description": "The percentage of patients, 18 years and older, who undergo a procedure utilizing non-depolarizing neuromuscular blockade (NMB) who have a documented quantitative train-of-four ratio of greater than or equal to 0.9 before tracheal extubation in the operating room, post-anesthesia care unit, non-operating room anesthetizing location or earliest extubation except those patients who have documented need for continued paralysis postoperatively or a train of four less than 0.9 which necessitating Sugammadex or Neostigmine administration.",
+    "description": "The percentage of patients, 18 years and older, who undergo a procedure utilizing non-depolarizing neuromuscular blockade (NMB) who have a documented quantitative train-of-four ratio of greater than or equal to 0.9 before tracheal extubation in the operating room, post-anesthesia care unit, non-operating room anesthetizing location or earliest extubation.",
     "nqfId": null,
     "measureType": "process",
     "isHighPriority": true,
@@ -15279,7 +15279,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": true,
-    "primarySteward": "U.S. Wound Registry in Collaboration with Intellicure, LLC",
+    "primarySteward": "U.S. Wound Registry",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
       "6853338"
@@ -15314,7 +15314,7 @@
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "U.S. Wound Registry in Collaboration with Intellicure, LLC",
+    "primarySteward": "U.S. Wound Registry",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
       "6853338"
@@ -15349,7 +15349,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": true,
-    "primarySteward": "U.S. Wound Registry in Collaboration with Intellicure, LLC",
+    "primarySteward": "U.S. Wound Registry",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
       "6853338"
@@ -15384,7 +15384,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": true,
-    "primarySteward": "U.S. Wound Registry in Collaboration with Intellicure, LLC",
+    "primarySteward": "U.S. Wound Registry",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
       "6853338"
@@ -15494,7 +15494,8 @@
     "primarySteward": "MSN Healthcare Solutions, LLC",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
-      "6394618"
+      "6394618",
+      "5303416"
     ],
     "allowedPrograms": [
       "mips",
@@ -15529,7 +15530,8 @@
     "primarySteward": "MSN Healthcare Solutions, LLC",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
-      "6394618"
+      "6394618",
+      "5303416"
     ],
     "allowedPrograms": [
       "mips",
@@ -15993,7 +15995,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
       "3927141"
@@ -16105,7 +16107,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "GIQuIC in Collaboration with American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and Health Catalyst",
+    "primarySteward": "GIQuIC",
     "firstPerformanceYear": 2024,
     "allowedVendors": [
       "5846856"
@@ -16160,9 +16162,7 @@
     "firstPerformanceYear": 2024,
     "allowedVendors": [
       "1718371",
-      "4757099",
-      "8483899",
-      "1725296"
+      "8483899"
     ],
     "allowedPrograms": [
       "mips",
@@ -16659,7 +16659,7 @@
   {
     "measureId": "AJRR9",
     "title": "Risk-Standardized Routine Discharge Rate Following Elective Primary Hip and Knee Arthroplasty",
-    "description": "Risk-standardized rate for routine discharge for elective primary total hip and knee arthroplasty",
+    "description": "Risk-standardized rate for routine discharge for elective primary total hip and knee arthroplasty.",
     "nqfId": null,
     "measureType": "outcome",
     "isHighPriority": true,
@@ -16669,7 +16669,8 @@
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "5224253",
-      "1157686"
+      "1157686",
+      "3967247"
     ],
     "allowedPrograms": [
       "mips",
@@ -16712,7 +16713,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Registry Clearinghouse in Collaboration with Ohio Foot and Ankle Medical Association",
+    "primarySteward": "Registry Clearinghouse",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "4117893"
@@ -16747,7 +16748,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "4067715"
@@ -16785,7 +16786,8 @@
     "primarySteward": "AAOS Orthopaedic Quality Resource Center",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
-      "5224253"
+      "5224253",
+      "3967247"
     ],
     "allowedPrograms": [
       "mips",
@@ -16981,7 +16983,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+    "primarySteward": "Practice Insights by McKesson - QCDR",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "7037323",
@@ -17018,10 +17020,11 @@
     "isHighPriority": true,
     "isInverse": true,
     "isRiskAdjusted": false,
-    "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+    "primarySteward": "Practice Insights by McKesson - QCDR",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
-      "8794712"
+      "8794712",
+      "2755787"
     ],
     "allowedPrograms": [
       "mips",
@@ -17053,10 +17056,11 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+    "primarySteward": "Practice Insights by McKesson - QCDR",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
-      "8794712"
+      "8794712",
+      "2755787"
     ],
     "allowedPrograms": [
       "mips",
@@ -17091,7 +17095,8 @@
     "primarySteward": "AAOS Orthopaedic Quality Resource Center",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
-      "5224253"
+      "5224253",
+      "3967247"
     ],
     "allowedPrograms": [
       "mips",
@@ -17123,7 +17128,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "1649514"
@@ -17198,8 +17203,9 @@
     "primarySteward": "The PQR",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
+      "5133825",
       "1725296",
-      "5133825"
+      "4757099"
     ],
     "allowedPrograms": [
       "mips",
@@ -17235,7 +17241,8 @@
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "6394618",
-      "7746687"
+      "7746687",
+      "5303416"
     ],
     "allowedPrograms": [
       "mips",
@@ -17270,8 +17277,9 @@
     "primarySteward": "The PQR",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
+      "5133825",
       "1725296",
-      "5133825"
+      "4757099"
     ],
     "allowedPrograms": [
       "mips",
@@ -17307,7 +17315,8 @@
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "6394618",
-      "7746687"
+      "7746687",
+      "5303416"
     ],
     "allowedPrograms": [
       "mips",
@@ -17374,7 +17383,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "ABG QCDR in Collaboration with Insight Medical Data Services, LLC",
+    "primarySteward": "ABG QCDR",
     "firstPerformanceYear": 2023,
     "allowedVendors": [
       "5551268",
@@ -17811,7 +17820,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "ABG QCDR in Collaboration with Insight Medical Data Services, LLC",
+    "primarySteward": "ABG QCDR",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "5551268",
@@ -17849,7 +17858,8 @@
     "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
     "firstPerformanceYear": 2016,
     "allowedVendors": [
-      "5133825"
+      "5133825",
+      "1725296"
     ],
     "allowedPrograms": [
       "mips",
@@ -17914,7 +17924,8 @@
     "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
     "firstPerformanceYear": 2016,
     "allowedVendors": [
-      "5133825"
+      "5133825",
+      "1725296"
     ],
     "allowedPrograms": [
       "mips",
@@ -17978,7 +17989,8 @@
     "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
-      "5133825"
+      "5133825",
+      "1725296"
     ],
     "allowedPrograms": [
       "mips",
@@ -18010,7 +18022,8 @@
     "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
-      "5133825"
+      "5133825",
+      "1725296"
     ],
     "allowedPrograms": [
       "mips",
@@ -18043,7 +18056,8 @@
     "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
-      "5133825"
+      "5133825",
+      "1725296"
     ],
     "allowedPrograms": [
       "mips",
@@ -18242,8 +18256,7 @@
     "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
-      "5133825",
-      "1725296"
+      "5133825"
     ],
     "allowedPrograms": [
       "mips",
@@ -18275,7 +18288,8 @@
     "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
-      "5133825"
+      "5133825",
+      "1725296"
     ],
     "allowedPrograms": [
       "mips",
@@ -18339,9 +18353,8 @@
     "primarySteward": "RISE (Rheumatology Informatics System for Effectiveness)",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
-      "3471690",
-      "5598408",
-      "3967247"
+      "3967247",
+      "5598408"
     ],
     "allowedPrograms": [
       "mips",
@@ -18366,7 +18379,7 @@
     "measureId": "ACR14",
     "title": "Gout: Serum Urate Target",
     "description": "The percentage of patients aged 18 and older with at least one clinician encounter (including telehealth) during the measurement period and a diagnosis of gout treated with urate-lowering therapy (ULT) for at least 12 months, whose most recent serum urate result is less than 6.0 mg/dL.",
-    "nqfId": "2549e",
+    "nqfId": "N/A",
     "measureType": "intermediateOutcome",
     "isHighPriority": true,
     "isInverse": false,
@@ -18374,9 +18387,8 @@
     "primarySteward": "RISE (Rheumatology Informatics System for Effectiveness)",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
-      "3471690",
-      "5598408",
-      "3967247"
+      "3967247",
+      "5598408"
     ],
     "allowedPrograms": [
       "mips",
@@ -18409,9 +18421,8 @@
     "primarySteward": "RISE (Rheumatology Informatics System for Effectiveness)",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
-      "3471690",
-      "5598408",
-      "3967247"
+      "3967247",
+      "5598408"
     ],
     "allowedPrograms": [
       "mips",
@@ -18476,10 +18487,11 @@
     "primarySteward": "American College of Radiology National Radiology Data Registry",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
-      "5303416",
       "6704504",
+      "7037323",
       "6394618",
-      "7037323"
+      "5303416",
+      "7746687"
     ],
     "allowedPrograms": [
       "mips",
@@ -18511,10 +18523,11 @@
     "primarySteward": "American College of Radiology National Radiology Data Registry",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
-      "5303416",
       "6704504",
+      "7037323",
       "6394618",
-      "7037323"
+      "5303416",
+      "7746687"
     ],
     "allowedPrograms": [
       "mips",
@@ -18546,10 +18559,11 @@
     "primarySteward": "American College of Radiology National Radiology Data Registry",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
-      "5303416",
       "6704504",
+      "7037323",
       "6394618",
-      "7037323"
+      "5303416",
+      "7746687"
     ],
     "allowedPrograms": [
       "mips",
@@ -18581,10 +18595,11 @@
     "primarySteward": "American College of Radiology National Radiology Data Registry",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
-      "5303416",
       "6704504",
+      "7037323",
       "6394618",
-      "7037323"
+      "5303416",
+      "7746687"
     ],
     "allowedPrograms": [
       "mips",
@@ -18616,10 +18631,11 @@
     "primarySteward": "American College of Radiology National Radiology Data Registry",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
-      "5303416",
       "6704504",
+      "7037323",
       "6394618",
-      "7037323"
+      "5303416",
+      "7746687"
     ],
     "allowedPrograms": [
       "mips",
@@ -18651,10 +18667,11 @@
     "primarySteward": "American College of Radiology National Radiology Data Registry",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
-      "5303416",
       "6704504",
+      "7037323",
       "6394618",
-      "7037323"
+      "5303416",
+      "7746687"
     ],
     "allowedPrograms": [
       "mips",
@@ -18836,7 +18853,7 @@
     "isHighPriority": true,
     "isInverse": true,
     "isRiskAdjusted": false,
-    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR) in Collaboration with American Society of Anesthesiologists (ASA)",
+    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR)",
     "firstPerformanceYear": 2016,
     "allowedVendors": [
       "5551268",
@@ -18872,7 +18889,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR) in Collaboration with American Society of Anesthesiologists (ASA)",
+    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR)",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
       "5551268",
@@ -18920,7 +18937,7 @@
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR) in Collaboration with American Society of Anesthesiologists (ASA)",
+    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR)",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
       "5551268",
@@ -18957,7 +18974,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR) in Collaboration with American Society of Anesthesiologists (ASA)",
+    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR)",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "5551268",
@@ -18994,7 +19011,7 @@
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR) in Collaboration with American Society of Anesthesiologists (ASA)",
+    "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR)",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "5551268",
@@ -19145,7 +19162,7 @@
   },
   {
     "measureId": "AQUA8",
-    "title": "Hospital admissions or infectious complications within 30 days of prostate biopsy",
+    "title": "Hospital Admissions or Infectious Complications Within 30 days of Prostate Biopsy",
     "description": "Percentage of patients with urinary retention, infection, inpatient consultation, or hospital admission for infection or sepsis within 30 days of undergoing a prostate biopsy",
     "nqfId": null,
     "measureType": "outcome",
@@ -19354,8 +19371,7 @@
     "firstPerformanceYear": 2018,
     "allowedVendors": [
       "1718371",
-      "4757099",
-      "1725296"
+      "4757099"
     ],
     "allowedPrograms": [
       "mips",
@@ -19423,8 +19439,7 @@
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "1718371",
-      "4757099",
-      "1725296"
+      "4757099"
     ],
     "allowedPrograms": [
       "mips",
@@ -19457,8 +19472,7 @@
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "1718371",
-      "4757099",
-      "1725296"
+      "4757099"
     ],
     "allowedPrograms": [
       "mips",
@@ -19521,7 +19535,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Anesthesia Quality Registry (AQR QCDR) in Collaboration with Anesthesia Quality Institute (AQI) and American Society of Anesthesiologists (ASA)",
+    "primarySteward": "Anesthesia Quality Registry (AQR QCDR)",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "6775913",
@@ -19554,7 +19568,7 @@
     "isHighPriority": true,
     "isInverse": true,
     "isRiskAdjusted": true,
-    "primarySteward": "Anesthesia Quality Registry (AQR QCDR) in Collaboration with Anesthesia Quality Institute (AQI) and American Society of Anesthesiologists (ASA)",
+    "primarySteward": "Anesthesia Quality Registry (AQR QCDR)",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "6169123",
@@ -19647,7 +19661,7 @@
   {
     "measureId": "FOTO7",
     "title": "Functional Status Change for Patients Post Stroke",
-    "description": "This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients aged 14 years and older who have experienced a stroke with sequelae impacting physical functional abilities. For patients with such conditions affecting use of the hand, arm, and upper trunk, the change in FS is assessed using the FOTO Stroke Upper Extremity (SUE) FS PROM. (1) For patients with such conditions affecting the foot, leg, and lower trunk, the change in FS is assessed using the FOTO Stroke Lower Extremity (SLE) FS PROM. (1) PROM cores were scaled to the 0-100 metric, with higher scores representing higher perceived functional status. In order to fairly measure performance between providers, the measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure (PM) at the patient and provider levels to assess quality.",
+    "description": "This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients aged 14 years and older who have experienced a stroke with sequelae impacting physical functional abilities. For patients with such conditions affecting use of the hand, arm, and upper trunk, the change in FS is assessed using the FOTO Stroke Upper Extremity (SUE) FS PROM.1 For patients with such conditions affecting the foot, leg, and lower trunk, the change in FS is assessed using the FOTO Stroke Lower Extremity (SLE) FS PROM.1 PROM cores were scaled to the 0-100 metric, with higher scores representing higher perceived functional status. In order to fairly measure performance between providers, the measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure (PM) at the patient and provider levels to assess quality.",
     "nqfId": null,
     "measureType": "patientReportedOutcome",
     "isHighPriority": true,
@@ -19685,7 +19699,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "GIQuIC in Collaboration with American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and Health Catalyst",
+    "primarySteward": "GIQuIC",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "5846856"
@@ -19787,8 +19801,7 @@
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "4757099",
-      "8483899",
-      "1725296"
+      "8483899"
     ],
     "allowedPrograms": [
       "mips",
@@ -19908,7 +19921,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2015,
     "allowedVendors": [
       "3927141"
@@ -19940,7 +19953,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2015,
     "allowedVendors": [
       "3927141"
@@ -19973,7 +19986,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2015,
     "allowedVendors": [
       "3927141"
@@ -20005,7 +20018,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2015,
     "allowedVendors": [
       "3927141"
@@ -20038,7 +20051,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
       "3927141"
@@ -20070,7 +20083,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "3927141"
@@ -20102,7 +20115,7 @@
     "isHighPriority": true,
     "isInverse": true,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "3927141"
@@ -20134,7 +20147,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "3927141"
@@ -20167,7 +20180,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "3927141"
@@ -20199,7 +20212,7 @@
     "isHighPriority": true,
     "isInverse": true,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "3927141"
@@ -20232,7 +20245,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+    "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "3927141"
@@ -20265,7 +20278,7 @@
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2018,
     "allowedVendors": [
       "4067715"
@@ -20297,7 +20310,7 @@
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "4067715"
@@ -20329,7 +20342,7 @@
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "4067715"
@@ -20361,7 +20374,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "4067715"
@@ -20393,7 +20406,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "4067715"
@@ -20425,7 +20438,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "4067715"
@@ -20457,7 +20470,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2018,
     "allowedVendors": [
       "4067715"
@@ -20490,7 +20503,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "4067715"
@@ -20523,7 +20536,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+    "primarySteward": "MBHR Mental and Behavioral Health Registry",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "4067715"
@@ -20589,7 +20602,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Registry Clearinghouse in Collaboration with Ohio Foot and Ankle Medical Association",
+    "primarySteward": "Registry Clearinghouse",
     "firstPerformanceYear": 2018,
     "allowedVendors": [
       "4117893"
@@ -20724,7 +20737,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "GIQuIC in Collaboration with American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and Health Catalyst",
+    "primarySteward": "GIQuIC",
     "firstPerformanceYear": 2015,
     "allowedVendors": [
       "5846856"
@@ -20757,7 +20770,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+    "primarySteward": "Practice Insights by McKesson - QCDR",
     "firstPerformanceYear": 2018,
     "allowedVendors": [
       "8794712"
@@ -20789,7 +20802,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+    "primarySteward": "Practice Insights by McKesson - QCDR",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "8794712"
@@ -20821,7 +20834,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+    "primarySteward": "Practice Insights by McKesson - QCDR",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "8794712"
@@ -20853,7 +20866,7 @@
     "isHighPriority": true,
     "isInverse": true,
     "isRiskAdjusted": false,
-    "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+    "primarySteward": "Practice Insights by McKesson - QCDR",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "8794712"
@@ -20923,7 +20936,8 @@
     "allowedVendors": [
       "5303416",
       "6394618",
-      "7746687"
+      "7746687",
+      "6704504"
     ],
     "allowedPrograms": [
       "mips",
@@ -21090,7 +21104,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group in Collaboration with Renal Physicians Association (RPA)",
+    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",
     "firstPerformanceYear": 2019,
     "allowedVendors": [
       "4302083"
@@ -21122,7 +21136,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group in Collaboration with Renal Physicians Association (RPA)",
+    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "4302083"
@@ -21154,7 +21168,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Registry Clearinghouse in Collaboration with Ohio Foot and Ankle Medical Association",
+    "primarySteward": "Registry Clearinghouse",
     "firstPerformanceYear": 2020,
     "allowedVendors": [
       "4117893"
@@ -21186,7 +21200,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Registry Clearinghouse in Collaboration with Ohio Foot and Ankle Medical Association",
+    "primarySteward": "Registry Clearinghouse",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "4117893"
@@ -21218,7 +21232,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Registry Clearinghouse in Collaboration with Ohio Foot and Ankle Medical Association",
+    "primarySteward": "Registry Clearinghouse",
     "firstPerformanceYear": 2021,
     "allowedVendors": [
       "4117893"
@@ -21250,7 +21264,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group in Collaboration with Renal Physicians Association (RPA)",
+    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",
     "firstPerformanceYear": 2016,
     "allowedVendors": [
       "4302083"
@@ -21282,7 +21296,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group in Collaboration with Renal Physicians Association (RPA)",
+    "primarySteward": "Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",
     "firstPerformanceYear": 2016,
     "allowedVendors": [
       "4302083"
@@ -21314,7 +21328,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
     "firstPerformanceYear": 2018,
     "allowedVendors": [
       "1649514"
@@ -21347,7 +21361,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "1649514"
@@ -21380,7 +21394,7 @@
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+    "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "1649514"
@@ -21407,13 +21421,13 @@
   {
     "measureId": "USWR22",
     "title": "Nutritional Assessment and Intervention Plan in patients with Wounds and Ulcers",
-    "description": "The percentage of patients in the denominator for whom an appropriate intervention plan is recommended by the practitioner based on the assessment results.",
+    "description": "The percentage of patients in the denominator for whom an appropriate intervention plan is recommended by the practitioner based on the assessment results",
     "nqfId": null,
     "measureType": "process",
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "U.S. Wound Registry in Collaboration with Intellicure, LLC",
+    "primarySteward": "U.S. Wound Registry",
     "firstPerformanceYear": 2017,
     "allowedVendors": [
       "6853338"
@@ -21439,13 +21453,13 @@
   {
     "measureId": "USWR30",
     "title": "Non-Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential",
-    "description": "Percentage of patients aged 18 years or older with a non-healing lower extremity wound or ulcer that undergo a non-invasive arterial assessment once in a 12-month period",
+    "description": "Percentage of patients aged 18 years or older with a non-healing lower extremity wound or ulcer that undergo a non-invasive arterial assessment once in a 12-month period.",
     "nqfId": null,
     "measureType": "process",
     "isHighPriority": false,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "U.S. Wound Registry in Collaboration with Intellicure, LLC",
+    "primarySteward": "U.S. Wound Registry",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "6853338"
@@ -21477,7 +21491,7 @@
     "isHighPriority": true,
     "isInverse": false,
     "isRiskAdjusted": false,
-    "primarySteward": "U.S. Wound Registry in Collaboration with Intellicure, LLC",
+    "primarySteward": "U.S. Wound Registry",
     "firstPerformanceYear": 2022,
     "allowedVendors": [
       "6853338"
@@ -21493,29 +21507,10 @@
     "measureSets": [],
     "isRegistryMeasure": true,
     "isIcdImpacted": false,
-    "metricType": "registryMultiPerformanceRate",
+    "metricType": "registrySinglePerformanceRate",
     "submissionMethods": [
       "registry"
     ],
-    "overallAlgorithm": "overallStratumOnly",
-    "strata": [
-      {
-        "name": "noRestrictions",
-        "description": "Normal arterial supply based on testing- No restrictions on type of compression"
-      },
-      {
-        "name": "specialConsideration",
-        "description": "Compression bandaging with special considerations (e.g., short stretch bandaging, warnings to the patient to remove bandages if they feel too tight, etc.)"
-      },
-      {
-        "name": "notRecommended",
-        "description": "Compression bandaging not recommended"
-      },
-      {
-        "name": "overall",
-        "description": "The average of the three risk stratified buckets which will be the performance rate in the JSON XML submitted."
-      }
-    ],
     "isSevenPointCapRemoved": false,
     "sevenPointCapRemoved": []
   }
diff --git a/mvp/2025/mvp-enriched.json b/mvp/2025/mvp-enriched.json
index c8b68b73..02d2ca8f 100644
--- a/mvp/2025/mvp-enriched.json
+++ b/mvp/2025/mvp-enriched.json
@@ -628,9 +628,8 @@
         "primarySteward": "RISE (Rheumatology Informatics System for Effectiveness)",
         "firstPerformanceYear": 2020,
         "allowedVendors": [
-          "3471690",
-          "5598408",
-          "3967247"
+          "3967247",
+          "5598408"
         ],
         "allowedPrograms": [
           "mips",
@@ -655,7 +654,7 @@
         "measureId": "ACR14",
         "title": "Gout: Serum Urate Target",
         "description": "The percentage of patients aged 18 and older with at least one clinician encounter (including telehealth) during the measurement period and a diagnosis of gout treated with urate-lowering therapy (ULT) for at least 12 months, whose most recent serum urate result is less than 6.0 mg/dL.",
-        "nqfId": "2549e",
+        "nqfId": "N/A",
         "measureType": "intermediateOutcome",
         "isHighPriority": true,
         "isInverse": false,
@@ -663,9 +662,8 @@
         "primarySteward": "RISE (Rheumatology Informatics System for Effectiveness)",
         "firstPerformanceYear": 2020,
         "allowedVendors": [
-          "3471690",
-          "5598408",
-          "3967247"
+          "3967247",
+          "5598408"
         ],
         "allowedPrograms": [
           "mips",
@@ -698,9 +696,8 @@
         "primarySteward": "RISE (Rheumatology Informatics System for Effectiveness)",
         "firstPerformanceYear": 2021,
         "allowedVendors": [
-          "3471690",
-          "5598408",
-          "3967247"
+          "3967247",
+          "5598408"
         ],
         "allowedPrograms": [
           "mips",
@@ -730,7 +727,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
         "firstPerformanceYear": 2018,
         "allowedVendors": [
           "1649514"
@@ -763,7 +760,7 @@
         "isHighPriority": false,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
         "firstPerformanceYear": 2022,
         "allowedVendors": [
           "1649514"
@@ -796,7 +793,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
         "firstPerformanceYear": 2023,
         "allowedVendors": [
           "1649514"
@@ -9733,7 +9730,8 @@
         "primarySteward": "ACEP's Clinical Emergency Data Registry (CEDR)",
         "firstPerformanceYear": 2020,
         "allowedVendors": [
-          "5133825"
+          "5133825",
+          "1725296"
         ],
         "allowedPrograms": [
           "mips",
@@ -15037,7 +15035,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "ABG QCDR in Collaboration with Insight Medical Data Services, LLC",
+        "primarySteward": "ABG QCDR",
         "firstPerformanceYear": 2023,
         "allowedVendors": [
           "5551268",
@@ -15078,7 +15076,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR) in Collaboration with American Society of Anesthesiologists (ASA)",
+        "primarySteward": "Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR)",
         "firstPerformanceYear": 2017,
         "allowedVendors": [
           "5551268",
@@ -15126,7 +15124,7 @@
         "isHighPriority": true,
         "isInverse": true,
         "isRiskAdjusted": true,
-        "primarySteward": "Anesthesia Quality Registry (AQR QCDR) in Collaboration with Anesthesia Quality Institute (AQI) and American Society of Anesthesiologists (ASA)",
+        "primarySteward": "Anesthesia Quality Registry (AQR QCDR)",
         "firstPerformanceYear": 2020,
         "allowedVendors": [
           "6169123",
@@ -18243,7 +18241,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "Practice Insights by McKesson in Collaboration with The US Oncology Network - QCDR",
+        "primarySteward": "Practice Insights by McKesson - QCDR",
         "firstPerformanceYear": 2023,
         "allowedVendors": [
           "7037323",
@@ -31412,7 +31410,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics) in Collaboration with HealthAdvanta",
+        "primarySteward": "UREQA (United Rheumatology Effectiveness and Quality Analytics)",
         "firstPerformanceYear": 2022,
         "allowedVendors": [
           "1649514"
@@ -40202,7 +40200,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+        "primarySteward": "MBHR Mental and Behavioral Health Registry",
         "firstPerformanceYear": 2018,
         "allowedVendors": [
           "4067715"
@@ -40235,7 +40233,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "MBHR Mental and Behavioral Health Registry in Collaboration with Healthmonix",
+        "primarySteward": "MBHR Mental and Behavioral Health Registry",
         "firstPerformanceYear": 2020,
         "allowedVendors": [
           "4067715"
@@ -46616,7 +46614,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
         "firstPerformanceYear": 2015,
         "allowedVendors": [
           "3927141"
@@ -46649,7 +46647,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
         "firstPerformanceYear": 2015,
         "allowedVendors": [
           "3927141"
@@ -46682,7 +46680,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
         "firstPerformanceYear": 2019,
         "allowedVendors": [
           "3927141"
@@ -46715,7 +46713,7 @@
         "isHighPriority": true,
         "isInverse": true,
         "isRiskAdjusted": false,
-        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
         "firstPerformanceYear": 2020,
         "allowedVendors": [
           "3927141"
@@ -46748,7 +46746,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
         "firstPerformanceYear": 2020,
         "allowedVendors": [
           "3927141"
@@ -46781,7 +46779,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) in Collaboration with Verana Health",
+        "primarySteward": "American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)",
         "firstPerformanceYear": 2024,
         "allowedVendors": [
           "3927141"
@@ -52892,7 +52890,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "GIQuIC in Collaboration with American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and Health Catalyst",
+        "primarySteward": "GIQuIC",
         "firstPerformanceYear": 2021,
         "allowedVendors": [
           "5846856"
@@ -52956,7 +52954,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "GIQuIC in Collaboration with American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and Health Catalyst",
+        "primarySteward": "GIQuIC",
         "firstPerformanceYear": 2024,
         "allowedVendors": [
           "5846856"
@@ -53007,7 +53005,7 @@
         "isHighPriority": true,
         "isInverse": false,
         "isRiskAdjusted": false,
-        "primarySteward": "GIQuIC in Collaboration with American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and Health Catalyst",
+        "primarySteward": "GIQuIC",
         "firstPerformanceYear": 2015,
         "allowedVendors": [
           "5846856"
@@ -55780,7 +55778,7 @@
       },
       {
         "measureId": "AQUA8",
-        "title": "Hospital admissions or infectious complications within 30 days of prostate biopsy",
+        "title": "Hospital Admissions or Infectious Complications Within 30 days of Prostate Biopsy",
         "description": "Percentage of patients with urinary retention, infection, inpatient consultation, or hospital admission for infection or sepsis within 30 days of undergoing a prostate biopsy",
         "nqfId": null,
         "measureType": "outcome",
diff --git a/updates/measures/2024/Quality_PY24_CR_20250103.csv b/updates/measures/2024/Quality_PY24_CR_20250103.csv
new file mode 100644
index 00000000..3c7c3016
--- /dev/null
+++ b/updates/measures/2024/Quality_PY24_CR_20250103.csv
@@ -0,0 +1,2 @@
+Category ,Measure Title,CMS eCQM ID,eCQM NQF,NQF,*** Quality Number (#) / QCDR #,Primary Measure Steward,Allowed QCDR Vendor ID,Measure Description,*** Measure Type  ,High Priority,First Performance Year,Year Removed,*** Collection Type(s) for Submission,Specialty Measure Sets,*** Inverse,*** Metric Type,*** Calculation Type,Collection Type(s) where Historic Benchmark Removed,Collection Type(s) where Suppressed,Collection Type(s) where Truncated,Collection Type(s) where Historic Benchmark Removed ** Special Rules **,Is Risk Adjusted 
+QCDR,,,,,USWR32,,,,,,,,,,,singlePerformanceRate,,,,,,
\ No newline at end of file
diff --git a/updates/measures/2024/changes.meta.json b/updates/measures/2024/changes.meta.json
index 9f6e6bb4..39d21882 100644
--- a/updates/measures/2024/changes.meta.json
+++ b/updates/measures/2024/changes.meta.json
@@ -19,5 +19,6 @@
   "Quality_QCDR_PY24_CR_20240416.csv",
   "Quality_Truncated_PY24_CR_20241002.csv",
   "QCDR_2024_ABFM13_AnalyticUpdate_CR_10042024.csv",
-  "Quality_PY24_CR_10182024.csv"
+  "Quality_PY24_CR_10182024.csv",
+  "Quality_PY24_CR_20250103.csv"
 ]
\ No newline at end of file
diff --git a/updates/measures/2025/Quality_QCDR_PY25_CR_20250103.csv b/updates/measures/2025/Quality_QCDR_PY25_CR_20250103.csv
new file mode 100644
index 00000000..49a22888
--- /dev/null
+++ b/updates/measures/2025/Quality_QCDR_PY25_CR_20250103.csv
@@ -0,0 +1,114 @@
+Category ,Measure Title,CMS eCQM ID,eCQM NQF,NQF,*** Quality Number (#) / QCDR #,Primary Measure Steward,Allowed QCDR Vendor ID,Measure Description,*** Measure Type ,High Priority,First Performance Year,Year Removed,*** Collection Type(s) for Submission,Specialty Measure Sets,*** Inverse,*** Metric Type,*** Calculation Type,Collection Type(s) where Historic Benchmark Removed,Collection Type(s) where Suppressed,Collection Type(s) where Truncated,*** Collection Type(s) where 7-point Cap Removed,Collection Type(s) where Historic Benchmark Removed ** Special Rules **,Is Risk Adjusted 
+QCDR,"Heart Failure (HF): SGLT-2 Inhibitor Therapy for Left Ventricular Systolic Dysfunction (LVSD)",,,,HCPR28,,,"Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) less than or equal to 40% who were prescribed SGLT-2 Inhibitors during their SNF stay or at the time of discharge",,,,,,,,,,,,,,,
+QCDR,"Opioid Withdrawal: Initiation of Medication for Opioid Use Disorder (MOUD) and Referral to Outpatient Opioid Treatment",,,,ECPR56,,,"Percentage of Patients Presenting with Opioid Withdrawal Who Were Given Medication for Opioid Use Disorder (MOUD) and Referred to Outpatient Opioid Treatment",,,,,,,,,,,,,,,
+QCDR,,,,,HCPR25,,,"Percentage of Patients with Advanced Illness with Physician’s Orders for Life-Sustaining Treatment (POLST) Forms Completed.",,,,,,,,,,,,,,,
+QCDR,,,,,QMM26,,,"Percentage of patients, aged 50-years-old or older, who have had a screening ultrasound for an abdominal aortic aneurysm (AAA), with positive or negative findings, that have recognized clinical follow up recommendations documented in the final report and direct communication of findings greater than or equal to 5.5 cm in size made to the ordering provider.",,,,,,,,,,,,,,,
+QCDR,Hospital Admissions or Infectious Complications Within 30 days of Prostate Biopsy,,,,AQUA8,,,,,,,,,,,,,,,,,,
+QCDR,,,,,USWR22,U.S. Wound Registry,,The percentage of patients in the denominator for whom an appropriate intervention plan is recommended by the practitioner based on the assessment results,,,,,,,,,,,,,,,
+QCDR,,,,,FOTO7,,,"This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients aged 14 years and older who have experienced a stroke with sequelae impacting physical functional abilities. For patients with such conditions affecting use of the hand, arm, and upper trunk, the change in FS is assessed using the FOTO Stroke Upper Extremity (SUE) FS PROM.1 For patients with such conditions affecting the foot, leg, and lower trunk, the change in FS is assessed using the FOTO Stroke Lower Extremity (SLE) FS PROM.1 PROM cores were scaled to the 0-100 metric, with higher scores representing higher perceived functional status. In order to fairly measure performance between providers, the measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure (PM) at the patient and provider levels to assess quality.",,,,,,,,,,,,,,,
+QCDR,,,,,AQI79,,,"The percentage of patients, 18 years and older, who undergo a procedure utilizing non-depolarizing neuromuscular blockade (NMB) who have a documented quantitative train-of-four ratio of greater than or equal to 0.9 before tracheal extubation in the operating room, post-anesthesia care unit, non-operating room anesthetizing location or earliest extubation.",,,,,,,,,,,,,,,
+QCDR,,,,,AQI78,,,"Percentage of patients, aged 70 and older, who undergo an elective surgical procedure under general anesthesia who receive a cognitive screening using a validated tool(s) within 90 days prior to their procedure and, for those who screen positive for cognitive impairment or cognitively at-risk, have two or more perioperative best practices for the older adult applied to their care. 
+
+Instructions:
+This measure consists of a weighted average of two performance rates: 
+Numerator Criteria 1:
+Patients received a cognitive screening using a validated tool within 90 days prior to their elective surgical procedure.    
+Numerator Criteria 2:
+Patients who screened positive for cognitive impairment or cognitively at risk (positive cognitive screening or positive cognitively at-risk) using a validated tool within 90 days prior to their elective surgical procedure received two or more of the perioperative best practices for the older adult applied to their care.
+
+It is anticipated that qualified anesthesia professionals and eligible clinicians who provide denominator-eligible services will submit this measure.",,,,,,,,,,,,,,,
+QCDR,,,,,AQI77,,,"Percentage of patients, 18 years and older, who undergo a surgical procedure requiring anesthesia services who are screened for risk of opioid use disorder using a standardized screening tool and, if the patient tests positive for risk of opioid use disorder, are referred to a treatment program according to facility policies and procedures.",,,,,,,,,,,,,,,
+QCDR,,,,,AJRR9,,"5224253, 1157686, 3967247",Risk-standardized rate for routine discharge for elective primary total hip and knee arthroplasty.,,,,,,,,,,,,,,,
+QCDR,,,,3617,ABFM14,,,,,,,,,,,,,,,,,,
+QCDR,,,,N/A,ACR14,,"3967247, 5598408",,,,,,,,,,,,,,,,
+QCDR,,,,,USWR32,U.S. Wound Registry,,,,,,,,,,singlePerformanceRate,,,,,,,
+QCDR,,,,,AJRR13,,,,Patient-Reported Outcome-Based Performance Measure,,,,,,,,,,,,,,
+QCDR,,,,,ABG42,ABG QCDR,,,,,,,,,,,,,,,,,
+QCDR,,,,,ABG44,ABG QCDR,,,,,,,,,,,,,,,,,
+QCDR,,,,,AQI18,Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR),,,,,,,,,,,,,,,,,
+QCDR,,,,,AQI48,Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR),,,,,,,,,,,,,,,,,
+QCDR,,,,,AQI49,Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR),,,,,,,,,,,,,,,,,
+QCDR,,,,,AQI65,Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR),,,,,,,,,,,,,,,,,
+QCDR,,,,,AQI71,Anesthesia Quality Institute (AQI) National Anesthesia Clinical Outcomes Registry (NACOR),,,,,,,,,,,,,,,,,
+QCDR,,,,,EPREOP30,Anesthesia Quality Registry (AQR QCDR),,,,,,,,,,,,,,,,,
+QCDR,,,,,EPREOP31,Anesthesia Quality Registry (AQR QCDR),,,,,,,,,,,,,,,,,
+QCDR,,,,,GIQIC23,GIQuIC,,,,,,,,,,,,,,,,,
+QCDR,,,,,GIQIC26,GIQuIC,,,,,,,,,,,,,,,,,
+QCDR,,,,,NHCR4,GIQuIC,,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS1,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS13,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS17,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS2,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS23,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS35,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS38,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS39,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS50,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS54,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS58,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,IRIS61,American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight),,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR1,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR11,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR13,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR14,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR15,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR16,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR18,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR2,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR7,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MBHR8,MBHR Mental and Behavioral Health Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,MEX5,Registry Clearinghouse,,,,,,,,,,,,,,,,,
+QCDR,,,,,PIMSH1,Practice Insights by McKesson - QCDR,,,,,,,,,,,,,,,,,
+QCDR,,,,,PIMSH10,Practice Insights by McKesson - QCDR,,,,,,,,,,,,,,,,,
+QCDR,,,,,PIMSH13,Practice Insights by McKesson - QCDR,,,,,,,,,,,,,,,,,
+QCDR,,,,,PIMSH15,Practice Insights by McKesson - QCDR,"8794712, 2755787",,,,,,,,,,,,,,,,
+QCDR,,,,,PIMSH16,Practice Insights by McKesson - QCDR,"8794712, 2755787",,,,,,,,,,,,,,,,
+QCDR,,,,,PIMSH4,Practice Insights by McKesson - QCDR,,,,,,,,,,,,,,,,,
+QCDR,,,,,PIMSH9,Practice Insights by McKesson - QCDR,,,,,,,,,,,,,,,,,
+QCDR,,,,,RCOIR12,"Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",,,,,,,,,,,,,,,,,
+QCDR,,,,,RCOIR13,"Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",,"Percentage of clinically successful percutaneously created arteriovenous fistulae (pAVF) for patients on maintenance hemodialysis.",,,,,,,,,,,,,,,
+QCDR,,,,,REGCLR1,Registry Clearinghouse,,,,,,,,,,,,,,,,,
+QCDR,,,,,REGCLR3,Registry Clearinghouse,,,,,,,,,,,,,,,,,
+QCDR,,,,,REGCLR5,Registry Clearinghouse,,,,,,,,,,,,,,,,,
+QCDR,,,,,REGCLR8,Registry Clearinghouse,,,,,,,,,,,,,,,,,
+QCDR,,,,,RPAQIR14,"Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",,,,,,,,,,,,,,,,,
+QCDR,,,,,RPAQIR15,"Renal and Vascular Outcomes Improvement Program, powered by Forward Health Group",,,,,,,,,,,,,,,,,
+QCDR,,,,,UREQA10,UREQA (United Rheumatology Effectiveness and Quality Analytics),,,,,,,,,,,,,,,,,
+QCDR,,,,,UREQA2,UREQA (United Rheumatology Effectiveness and Quality Analytics),,,,,,,,,,,,,,,,,
+QCDR,,,,,UREQA8,UREQA (United Rheumatology Effectiveness and Quality Analytics),,,,,,,,,,,,,,,,,
+QCDR,,,,,UREQA9,UREQA (United Rheumatology Effectiveness and Quality Analytics),,,,,,,,,,,,,,,,,
+QCDR,,,,,USWR30,U.S. Wound Registry,,"Percentage of patients aged 18 years or older with a non-healing lower extremity wound or ulcer that undergo a non-invasive arterial assessment once in a 12-month period.",,,,,,,,,,,,,,,
+QCDR,,,,,USWR33,U.S. Wound Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,USWR34,U.S. Wound Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,USWR35,U.S. Wound Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,USWR36,U.S. Wound Registry,,,,,,,,,,,,,,,,,
+QCDR,,,,,ACEP22,,"5133825, 1725296",,,,,,,,,,,,,,,,
+QCDR,,,,,ACEP30,,"5133825, 1725296",,,,,,,,,,,,,,,,
+QCDR,,,,,ACEP48,,"5133825, 1725296",,,,,,,,,,,,,,,,
+QCDR,,,,,ACEP50,,"5133825, 1725296",,,,,,,,,,,,,,,,
+QCDR,,,,,ACEP51,,"5133825, 1725296",,,,,,,,,,,,,,,,
+QCDR,,,,,ACEP61,,5133825,,,,,,,,,,,,,,,,
+QCDR,,,,,ACEP62,,"5133825, 1725296",,,,,,,,,,,,,,,,
+QCDR,,,,,ACR12,,"3967247, 5598408",,,,,,,,,,,,,,,,
+QCDR,,,,,ACR15,,"3967247, 5598408",,,,,,,,,,,,,,,,
+QCDR,,,,,ACRAD15,,"6704504, 7037323, 6394618, 5303416, 7746687",,,,,,,,,,,,,,,,
+QCDR,,,,,ACRAD16,,"6704504, 7037323, 6394618, 5303416, 7746687",,,,,,,,,,,,,,,,
+QCDR,,,,,ACRAD17,,"6704504, 7037323, 6394618, 5303416, 7746687",,,,,,,,,,,,,,,,
+QCDR,,,,,ACRAD18,,"6704504, 7037323, 6394618, 5303416, 7746687",,,,,,,,,,,,,,,,
+QCDR,,,,,ACRAD19,,"6704504, 7037323, 6394618, 5303416, 7746687",,,,,,,,,,,,,,,,
+QCDR,,,,,ACRAD25,,"6704504, 7037323, 6394618, 5303416, 7746687",,,,,,,,,,,,,,,,
+QCDR,,,,,AJRR10,,"5224253, 3967247",,,,,,,,,,,,,,,,
+QCDR,,,,,AJRR7,,"5224253, 3967247",,,,,,,,,,,,,,,,
+QCDR,,,,,ECPR50,,"1718371, 4757099",,,,,,,,,,,,,,,,
+QCDR,,,,,ECPR52,,"1718371, 4757099",,,,,,,,,,,,,,,,
+QCDR,,,,,ECPR55,,"1718371, 4757099",,,,,,,,,,,,,,,,
+QCDR,,,,,ECPR59,,"1718371, 8483899",,,,,,,,,,,,,,,,
+QCDR,,,,,HCPR23,,"4757099, 8483899",,,,,,,,,,,,,,,,
+QCDR,,,,,QMM16,,"5303416, 6394618, 7746687, 6704504",,,,,,,,,,,,,,,,
+QCDR,,,,,QMM23,,"6394618, 7746687, 5303416",,,,,,,,,,,,,,,,
+QCDR,,,,,QMM24,,"6394618, 7746687, 5303416",,,,,,,,,,,,,,,,
+QCDR,,,,,QMM27,,"6394618, 5303416",,,,,,,,,,,,,,,,
+QCDR,,,,,QMM28,,"6394618, 5303416",,,,,,,,,,,,,,,,
+QCDR,,,,,THEPQR1,,"5133825, 1725296, 4757099",,,,,,,,,,,,,,,,
+QCDR,,,,,THEPQR2,,"5133825, 1725296, 4757099",,,,,,,,,,,,,,,,
+QCDR,,,,,AQI76,,,"Percentage of patients, aged 70 and older, undergoing an inpatient procedure under general anesthesia and who received a frailty screening using a validated tool(s) within 90 days of the procedure and up to ten minutes before anesthesia start time and, for those who screen positive for frailty, receive a referral or have three best practices applied to their care.",,,,,,,,,,,,,,,
diff --git a/updates/measures/2025/changes.meta.json b/updates/measures/2025/changes.meta.json
index 0bac02bc..d1277b89 100644
--- a/updates/measures/2025/changes.meta.json
+++ b/updates/measures/2025/changes.meta.json
@@ -13,5 +13,6 @@
   "Quality_PY2025_DWH_Repo Compare Updates_CR_12182024.csv",
   "PI_PY25_CR_20241224.csv",
   "Quality_PY2025_DWH_Repo Compare Updatesv2_CR_12312024.csv",
-  "Quality_PY25_CR_20241224-1.csv"
+  "Quality_PY25_CR_20241224-1.csv",
+  "Quality_QCDR_PY25_CR_20250103.csv"
 ]
\ No newline at end of file